Sun Pharma Announces $11.75 Billion Acquisition of Organon & Co.
Sun Pharma has announced an $11.75 billion all-cash acquisition of global healthcare firm Organon & Co. – one of the largest overseas deals by an Indian company – to expand globally beyond generics.
Sun Pharmaceutical Industries (Sun Pharma) has announced a plan to buy the global healthcare company Organon & Co. for $11.75 billion in an all-cash deal. This is one of the largest overseas acquisitions ever made by an Indian company.
An all-cash deal means the buyer pays the full amount in cash rather than offering shares. The acquisition is part of Sun Pharma’s strategy to expand its business across the world and to grow beyond its traditional generic medicines.
Through this deal, Sun Pharma will strengthen its presence in many countries and move into high-growth areas such as women’s health and biosimilars. Organon brings a large product portfolio and a wide global reach.
For exam aspirants, this development is important because it reflects the growing global ambitions of Indian companies. Sun Pharma is one of India’s leading pharmaceutical firms, and the deal aims to make it a major global player in the sector.
Key Points to Remember
- Sun Pharma to acquire Organon & Co. for $11.75 billion
- It is an all-cash deal (paid fully in cash)
- Among the largest overseas acquisitions by an Indian firm
- Strengthens presence in women’s health and biosimilars
- Aims to reduce dependence on traditional generic medicines
Exam Relevance
Relevant for UPSC Prelims (Economy – Indian Industry), SSC CGL (General Awareness) and Banking exams (Business & Economy news).
Related Articles
India Plans to Export Vande Bharat Trains, Develops Standard-Gauge Version
India is developing a standard-gauge version of the Vande Bharat Express to enter export markets. …
US Trade Delegation to Visit India from 1–4 June 2026 for Trade …
A US delegation will visit India from 1–4 June 2026 to finalise an interim bilateral …
Supreme Court Upholds 28% GST on Online Gaming, Allows Retrospective Tax Demands
The Supreme Court upheld the 28% GST on online gaming and allowed retrospective tax demands …
India's Project Stalling Rate Falls to 12-Year Low of 5.5% in FY26
India's project stalling rate dropped to a 12-year low of 5.5% in FY26, down from …
Cabinet Approves ₹25,530 Crore Extension of Sarthak-PDS to Bring AI into Ration …
The Union Cabinet approved a ₹25,530 crore, five-year extension of the Sarthak-PDS scheme to use …